Cover Image
市場調查報告書

美國的特殊醫藥品市場

The US Specialty Pharmaceutical Market: Industry Analysis & Outlook 2017-2021

出版商 Koncept Analytics 商品編碼 253172
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
美國的特殊醫藥品市場 The US Specialty Pharmaceutical Market: Industry Analysis & Outlook 2017-2021
出版日期: 2017年12月07日 內容資訊: 英文 79 Pages
簡介

本報告提供美國的特殊醫藥品市場相關調查分析,概要,市場規模,市場趨勢,競爭情形等,也包含主要企業簡介,為您概述為以下內容。

第1章 市場概要

  • 簡介
  • 特殊醫藥品 vs. 傳統的醫藥品
  • 特殊醫藥品的用途
  • 特殊醫藥品用藥局服務
  • 特殊醫藥品的流通
  • 特殊醫藥品廠商服務
  • 特殊醫藥品用藥局的價值命題

第2章 美國的醫藥品市場分析

  • 美國的醫藥品市場:收益
  • 美國的醫藥品市場:收益預測
  • 美國的醫藥品市場:各市場區隔
  • 美國的醫藥品市場上需求的成長趨勢
  • 美國的醫藥品市場上藥物核准:各市場區隔
  • 美國的醫藥品市場:各藥物

第3章 美國的特殊醫藥品市場

  • 美國的特殊醫藥品市場:收益
  • 美國的特殊醫藥品市場:收益預測
  • 美國的特殊醫藥品市場:各藥物
  • 美國的特殊醫藥品市場:處方數

第4章 市場動態

  • 成長促進因素
  • 趨勢與機會
  • 課題

第5章 競爭情形

  • 美國的特殊醫藥品市場
  • 美國的特殊醫藥品市場:各治療等級
  • 特殊醫藥品藥局的佔有率
  • 特殊醫藥品的流通市場佔有率

第6章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The US pharmaceutical market is segregated into two types of drugs majorly i.e. traditional drugs and specialty drugs. Specialty drugs in recent times have gained a strong foothold in the US and are likely to experience robust growth in the coming years, with majority of the pharmaceutical companies heading their research and development initiatives towards these drugs.

Specialty drugs are basically meant for chronic and rare disease. Drugs in this category are very expensive and difficult to administer. Also, these drugs require proper management and special handling making them costly. Since, a large part of population in the US is ageing into diseases like cancer, and other deadly diseases, the demand for specialty drugs has skyrocketed in recent times.

The US specialty pharmaceutical market has changed over the span of five years with a lot of these drugs being in their final phase of development. The US specialty pharmaceutical market is likely to grow at staggering growth rate in the coming years majorly due to factors like ageing population of the US, improving life expectancy, rise in real net per capita medicine spending on specialty drugs, and high prevalence of chronic disease in the region.

The market is also undergoing some notable changes that have been covered in the report. The market growth is likely to be hindered by abandonment rate of specialty medicines and high R&D costs. The report offers an in-depth analysis of the "The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)". Major pharmaceutical companies that have been covered in the report include Celgene Corporation, Gilead Sciences Inc., Amgen Inc., and AbbVie Inc.

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Specialty Pharmaceuticals Vs Traditional Drugs
  • 1.3 Application of Specialty Pharmaceuticals
  • 1.4 Specialty Pharmacy Services
  • 1.5 Specialty Product Distribution
  • 1.6 Specialty Pharma Manufacturer Services
  • 1.7 Value Proposition of Specialty Pharmacy

2. The US Pharmaceutical Market Analysis

  • 2.1 The US Pharmaceutical Market by Value
  • 2.2 The US Pharmaceutical Market Forecast by Value
  • 2.3 The US Pharmaceutical Market by Segment
    • 2.3.1 The US Pharmaceutical Market by Segment
    • 2.3.2 The US Pharmaceutical Market by Segment Forecast
    • 2.3.3 The US Traditional Pharmaceutical Market by Value
    • 2.3.4 The US Traditional Pharmaceutical Market Forecast by Value
  • 2.4 The US Pharmaceutical Market's Demand Growth
  • 2.5 The US Pharmaceutical Market's Drug Approval by Segment
  • 2.6 The US Pharmaceutical Market by Drugs

3. The US Specialty Pharmaceutical Market

  • 3.1 The US Specialty Pharmaceutical Market by Value
  • 3.2 The US Specialty Pharmaceutical Market Forecast by Value
  • 3.3 The US Specialty Pharmaceutical Market by Drugs
  • 3.4 The US Specialty Pharmaceutical- Prescription Volume
    • 3.4.1 The US Specialty Medication Prescription Volume
    • 3.4.2 The US Specialty Medication Prescription Volume Forecast
    • 3.4.3 The US Specialty Medication Prescription Volume by Therapeutic Class
    • 3.4.4 The US Specialty Medication Prescription Volume Forecast by Therapeutic Class

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Rise in Ageing Population of the US
    • 4.1.2 Improving Life Expectancy
    • 4.1.3 Surge in Spending on Medicines
    • 4.1.4 Escalating Per Capita Heath Expenditure in the US
    • 4.1.5 Prevalence of Chronic Disease in the US
  • 4.2 Trend and Opportunities
    • 4.2.1 Technology Enabled Transformation
    • 4.2.2 Growing Foothold of Oncology Segment
    • 4.2.3 Specialty Pharmacy Mergers and Acquisitions
  • 4.3 Challenges and Issues
    • 4.3.1 High Cost of Drugs
    • 4.3.2 Abandonment Rates for Branded Medicines
    • 4.3.3 High R&D Costs

5. Competitive Landscape

  • 5.1 The US Specialty Pharmaceutical Market
    • 5.1.1 Revenue Comparison by Major Players
  • 5.2 The US Specialty Pharmaceutical Market by Therapeutic Class
    • 5.2.1 The US Specialty Inflammatory Conditions Market Share by Drugs
    • 5.2.2 The US Specialty Oncology Market Share by Drugs
    • 5.2.3 The US Specialty Multiple Sclerosis Market Share by Drugs
    • 5.2.4 The US Specialty HIV Market Share by Drugs
    • 5.2.5 The US Specialty Hepatitis C Market Share by Drugs
  • 5.3 The US Specialty Drug Pharmacies Market Share
  • 5.4 The US Specialty Product Distribution Market Share

6. Company Profiles

  • 6.1 Gilead Sciences Inc.
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 AbbVie Inc.
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Amgen Inc.
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Celgene Corporation
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Flow of Products within the Specialty Pharmacy Channel
  • SP Benefits Model
  • The US Pharmaceutical Market by Value (2012-2016)
  • The US Pharmaceutical Market Forecast by Value (2017-2021)
  • The US Pharmaceutical Market by Segment (2016)
  • The US Pharmaceutical Market by Segment Forecast (2021)
  • The US Traditional Pharmaceutical Market by Value (2012-2016)
  • The US Traditional Pharmaceutical Market Forecast by Value (2017-2021)
  • The US Pharmaceutical Market's Demand Growth by Segment (2012-2016)
  • The US Pharmaceutical Market's Drug Approval by Segment (2016)
  • The US Specialty Pharmaceutical Market by Value (2012-2016)
  • The US Specialty Pharmaceutical Market Forecast by Value (2017-2021)
  • The US Specialty Medication Prescription Volume (2012-2016)
  • The US Specialty Medication Prescription Volume Forecast (2017-2021)
  • The US Specialty Medication Prescription Volume by Therapeutic Class (2016)
  • The US Specialty Medication Prescription Volume Forecast by Therapeutic Class (2021)
  • The US Ageing Population by Age Bracket (2012-2016)
  • The US Life Expectancy-65 Years and Above (2012-2016)
  • Total Spending on Medicines in the US (2012-2016)
  • Real Net per Capita Medicine Spending on Specialty Drugs (2012-2016)
  • Total Per Capita Health Expenditure in the US (2012-2017)
  • Prevalence of Chronic Disease in the US (2015-2030)
  • Abandonment Rates for Branded Medicines in Commercial Plans (2016)
  • The US Specialty Inflammatory Conditions Market Share by Drugs (2016)
  • The US Specialty Oncology Market Share by Drugs (2016)
  • The US Specialty Multiple Sclerosis Market Share by Drugs (2016)
  • The US Specialty HIV Market Share by Drugs (2016)
  • The US Specialty Hepatitis C Market Share by Drugs (2016)
  • Gilead Sciences Inc. Revenue Share by Product (2016)
  • Gilead Sciences Inc. Revenue and Net Income (2012-2016)
  • AbbVie Inc. Revenue Share by Products (2016)
  • AbbVie Inc. Revenue and Net Earnings (2012-2016)
  • Amgen Inc. Revenue Share by Region (2016)
  • Amgen Inc. Revenue and Net Income (2012-2016)
  • Celgene Corporation's Revenue Share by Products (2016)
  • Celgene Corporation's Revenue and Net Income (2012-2016)

List of Tables

  • Specialty Pharmaceuticals - Key Application Areas
  • Specialty Pharmacy v/s Specialty Distributors
  • The US Pharmaceutical Market by Top 10 Drugs (2016)
  • The US Specialty Pharmaceutical Market by Parameters (2016)
  • Specialty Pharmacy Mergers and Acquisitions in the US (2016)
  • Price Range of Most Expensive Specialty Drugs in the US (2016)
  • The US Specialty Pharmaceutical Market Revenue Comparison by Major Players (2016)
  • The US Specialty Drug Pharmacies Market Share (2016)
  • The US Specialty Product Distribution Market Share by Company (2016)
  • Amgen Inc. Product Developments (2016)
Back to Top